Claritev

Claritev Receivables

The Accounts Receivable of Claritev (CTEV) as of Oct 17, 2026 is 127.62 M USD. In the previous year, Accounts Receivable was 89.76 M USD — a change of 42.18% (higher).

Receivables

127.62 MUSD

YoY

42.18%

Last updated:

Accounts Receivable of Claritev is 2025 127.62 M USD. Accounts Receivable of Claritev was 2024 89.76 M USD. It decreases by 42.18% higher compared to the previous year.

The Claritev Receivables history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Receivables
Date
Receivables
Jan 1, 2019
77.10 M USD
Jan 1, 2020
63.20 M USD
Jan 1, 2021
99.90 M USD
Jan 1, 2022
78.90 M USD
Jan 1, 2023
76.56 M USD
Jan 1, 2024
89.76 M USD
Jan 1, 2025
127.62 M USD
The Claritev Receivables history
YEARReceivablesYoY
127.62 MUSD+42.18%
89.76 MUSD+17.24%
76.56 MUSD-2.97%
78.90 MUSD-21.02%
99.90 MUSD+58.07%
63.20 MUSD-18.03%
77.10 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Claritev Stock analysis

What does Claritev do? Claritev Corp, listed under the ticker CTEV with ISIN US62548M2098, is a health care company headquartered in New York City, United States. The company has 3,000 employees and completed its initial public offering on February 10, 2020. Claritev Corp operates within the health care sector, focusing on providing healthcare cost management solutions. Its services include analytics-based approaches to identify over-charges in medical claims, negotiating fair reimbursement for out-of-network costs, and developing preferred provider networks through contracted discounts with healthcare providers. The company also offers payment and revenue integrity services designed to detect and correct improper or unnecessary charges before or after claims processing, as well as solutions to address underpaid premium dollars. Claritev Corp utilizes a software-as-a-service platform that processes and analyzes data using descriptive, predictive, and prescriptive analytics to support its services. The company's website is https://www.multiplan.us/. Claritev Corp is engaged in the delivery of data-driven solutions aimed at optimizing healthcare spending and improving financial outcomes for its clients in the health care industry. Claritev is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Claritev stock

Accounts Receivable of Claritev is 127.62 M USD in 2025.

Accounts Receivable of Claritev changed from 89.76 M USD to 127.62 M USD, representing a 42.18% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Accounts Receivable Claritev since 2006 – with annual values, charts, and detailed analysis.

Receivables represent money owed to the company by customers for goods or services delivered. High receivables relative to revenue may indicate collection issues.

Accounts Receivable's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Accounts Receivable's Claritev historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Claritev

All Key Metrics — Claritev